PipelinePharma Logo

vinpocetine Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21424

Established in 1987, this Manufacturer is a fully integrated biopharmaceutical entity specializing in human insulin, analogue insulin, and GLP-1 agents, offering both drug substances and formulations. As a CTD dossier owner and manufacturer, it provides comprehensive services from proof of concept to commercial scale, including yield optimization and contract manufacturing in vials, ampoules, cartridges, and disposable pens. Operating two manufacturing facilities—one in Taloja, Navi Mumbai, certified with WHO-GMP compliance to PIC standards, and another in Pune adhering to European Medicines Evaluation Agency (EMEA) and US FDA standards—the Manufacturer ensures high-quality production. With a workforce of approximately 500 employees, its products are accredited in over 30 countries and regions worldwide. As a GMP manufacturer, it maintains stringent quality standards across all operations. Committed to global health, this CTD dossier owner and manufacturer continues to expand its presence in regulated markets

Vinpocetine:

Vinpocetine, also known by the name ethyl apovincaminate, is a synthetic derivative of the vinca alkaloid vincamine. Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor. A lesser periwinkle (evergreen plant of the genus Vinca). While originally termed a dietary supplement, in recent years vinpocetine has been produced by pharmaceutical products manufacturers for clinical use in Europe. Where it is used as a medication or treatment of cerebrovascular disorders such as stroke and dementia. It and similar drugs have however not been given regulatory approval in the United States for sale on the medical marketplace. The sale of vinpocetine as a supplement is banned in Australia, New Zealand, and Canada due to "potential harmful nootropic characteristics" and evidence of its beneficial properties regarding either dementia or stroke therapies is disputed. Regardless, due to the existing support in certain regions, vinpocetine manufactures and vinpocetine suppliers produce it for sale. Where it can commonly be found on the global marketplace ready for order from distributors at wholesale for a variety of cost and price points.

Method of action of Vinpocetine:

The specifics of vinpocetine action remains unknown. However, the mechanism of action is postulated to involve three potential effects. The blockage of sodium channels, reduction of cellular calcium influx, and the modulation of antioxidant activity.

Form and dosage of vinpocetine:

As with all pharmaceutical products and drugs, the final form and packaging of vinpocetine is dependent on the manufacturers and suppliers, as well as the specific distributors and order. Due to the nature of vinpocetine, it can commonly be found for wholesale and sale in forms including tablets, capsules, concentrate for solution for infusion, solution for injection, vials, and ampules. Dosing is depending on the individual and the specific indication being treated. For further information please refer to an accredited medical professional or refer to the manufacturers’ literature.

Vinpocetine on Pipelinepharma:

Currently, at the time of writing, we have found 18 verified vinpocetine manufacturers and vinpocetine suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries such as the European Union, Ukraine, and Belarus. Each company and its pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of vinpocetine and how to buy:

The cost of vinpocetine is highly dependent on numerous factors such as form, purity, intention, location, and market. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find newly qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.